HomeAKTX • NASDAQ
add
Akari Therapeutics PLC
Previous close
$0.77
Day range
$0.75 - $0.80
Year range
$0.57 - $3.85
Market cap
25.73M USD
Avg Volume
76.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.12M | -43.85% |
Net income | -1.90M | 74.93% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.12M | 43.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.71M | -35.10% |
Total assets | 50.91M | 902.97% |
Total liabilities | 25.31M | 188.26% |
Total equity | 25.60M | — |
Shares outstanding | 32.61M | — |
Price to book | 0.97 | — |
Return on assets | -15.31% | — |
Return on capital | -30.73% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.90M | 74.93% |
Cash from operations | -3.26M | 33.47% |
Cash from investing | — | — |
Cash from financing | 3.38M | -56.45% |
Net change in cash | 129.00K | -95.50% |
Free cash flow | -4.55M | -337.21% |
About
Founded
2004
Headquarters
Website
Employees
9
